A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 54-59

  Chua, Keng Ling ^a   Wiklund, Fredrik ^b   Lenner, Per ^b   Ångström, Tord ^b   Hallmans, Göran ^b   Bergman, Frank ^b   Sapp, Martin ^c   Schiller, John ^d   Wadell, Göran ^b   Hjerpe, Anders ^a   Dillner, Joakim ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; SEROLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TUMOR VIRUS INFECTIONS; VAGINAL SMEARS;

EID: 10244222268     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO;2-6     Document Type: Article

References (30)

1. ANDERSSON-ELLSTRÖM, A., DILLNER, J., HAGMAR, B., SCHILLER, J., SAPP, M., FORSSMAN, L. and MILSOM, I., Comparison of development of serum antibodies to HPV 16 and HPV 33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex. transm. Dis. 23, 234-238 (1996).
2. CHUA, K.L. and HJERPE, A., Polymerase-chain-reaction (PCR) analysis of human papillomavirus (HPV) in archival smears. Anal. quant. Cytol. Histol., 17, 221-229 (1995).
3. CHUA, K.L. and HJERPE, A., Persistence of human-papillomavirus (HPV) infections preceding cervical carcinoma. Cancer, 77, 121-127 (1996).
4. DE RODA HUSMAN, A-M., SNIJDERS, P.J.F., STEL, H.V., VAN DEN BRULE, A.J.C., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Processing of long-stored archival cervical smears for human-papillomavirus detection by the polymerase chain reaction. Brit. J. Cancer, 72, 412-417 (1995a).
5. DE RODA HUSMAN, A-M., WALBOOMERS, J.M.M., VAN DEN BRULE, A.J.C., MEIJER, C.J.L.M. and SNIJDERS, P.J.F., The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human-papillomavirus detection by PCR. Gen. Virol., 76, 1057-1062 (1995b).
6. DILLNER, J., Serology of human papillomavirus. Cancer J., 8, 264-269 (1995).
7. DILLNER, J., KALLINGS, I., BRIHMER, C., SIKSTRÖM, B., KOSKELA, P., LEHTINEN, M., SCHILLER, J.T., SAPP, M. and MÅRDH, P.A., Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to chlamydia trachomatis are markers of sexual behaviour. J. infect Dis., 173, 1394-1398 (1996).
8. DILLNER, J., LENNER, P., LEHTINEN, M., EKLUND, C., HEINO, P., WIKLUND, F., HALLMANS, G. and STENDAHL, U., A population-based sero-epidemiological study of cervical cancer. Cancer Res., 54, 134-141 (1994).
9. DILLNER, J., WIKLUND, F., LENNER, P., EKLUND, C., FREDRIKSSON-SHANAZARIAN, V., SCHILLER, J.T., HIBMA, M., HALLMANS, G. and STENDAHL, U., Antibodies against linear and conformational epitomes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer, 60, 377-382 (1995).
10. EVANDER, M., BODEN, E., BJERSING, L., RYLANDER, E. and WADELL, G., Oligonucleotide primers for DNA amplification of the early regions 1, 6 and 7 from human papillomavirus types 6, 11, 16, 18, 31 and 33. Arch. Virol., 116, 221-235 (1991).
11. EVANDER, M., EDLUND, K., BODEN, E., GUSTAFSSON, Å., JONSSON, M., KARLSSON, R., RYLANDER, E. and WADELL, G., Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human-papillomavirus infection in young Swedish women. J. clin. Microbiol., 30, 987-992 (1992).
12. EVANDER, M., EDLUND, K., GUSTAFSSON, Å., JONSSON, M., KARLSSON, R., RYLANDER, E. and WADELL, G., Human-papillomavirus infection is transient in young women: a population-based cohort study. J. infect. Dis., 171, 1026-1030 (1995).
13. FLEISS, J.L., Statistical methods for the rates and proportions, pp. 143-147, John Wiley, New York (1973).
14. HEINO, P., EKLUND, C., FREDRIKSSON-SHAHNAZARIAN, V., GOLDMAN, S., SCHILLER, J.T. and DILLNER, J., Association of serum IgG antibodies against human-papillomavirus-type-16 capsids with anal epidemoid carcinoma. J. nat. Cancer Inst., 87, 437-440 (1995).
15. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P. and SHERMAN, M.E., Persistence of type-specific human-papillomavirus infection among cytologically normal women. J. infect. Dis., 169, 235-240 (1994).
16. HO, G.Y., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human-papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1371 (1995).
17. KIRNBAUER, R., HUBBERT, N.L., WHELLER, C.M., BECKER, T.M., LOWY, D.R. and SCHILLER, J.T., A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 494-498 (1994).
18. KIRNBAUER, R., TAUB, J., GREENSTONE, H., RODEN, R., DURST, M., GISSMANN, L., LOWY, D.R. and SCHILLER, J.T., Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol., 67, 6929-6936 (1993).
19. KOSS, L.G. (ed.), Diagnostic cytology and its histopathologic basis, 3rd ed., Lippincott, Philadelphia, Toronto (1979).
20. LEY, C., BAUER, H.M., REINGOLD, A., SCHIFFMAN, M.H., CHAMBERS, J.C., TASHIRO, C.J. and MANOS, M.M., Determinants of genital human-papillomavirus infection in young women. J. nat. Cancer Inst., 83, 997-1003 (1991).
21. MELKERT, P.W., HOPMAN, E., VAN DEN BRULE, A.J., RISSE, E.K., VAN DIEST, P.J., BLEKER, O.P., HELMERHORST, T., SCHIPPER, M.E., MEIJER, C.J. and WALBOOMERS, J.M., Presence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int. J. Cancer, 53, 919-923 (1993).
22. NASIELL, K., NASIELL, M. and VACLAVINKOVA, V., Behaviour of moderate cervical dysplasia during long-term follow-up. Obstet. Gynecol., 61, 609-614 (1983).
23. RHOADS, D.D., DIXIT, A. and ROUFA, D.J., Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol. cell. Biol., 6, 2774-2783 (1986).
24. SCHIFFMAN, M.H., Recent progress in defining the epidemiology of human-papillomavirus infection and cervical neoplasia. J. nat. Cancer Inst., 84, 394-398 (1992).
25. SCHIFFMAN, M.H., BAUER, H.M., HOOVER, R.N., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, C.K. and MANOS, M.M., Epidemiologic evidence showing that human-papillomavirus infection causes most cervical intra-epithelial neoplasia. J. nat. Cancer Inst., 85, 958-964 (1993).
26. TING, Y. and MANOS, M.M., Detection and typing of genital human papillomavirus. In: (Eds., Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J.) PCR protocols: a guide to methods and applications, pp. 356-367, Academic Press, New York (1990).
27. VOLPERS, C., SCHIRMACHER, P., STREECK, R.E. and SAPP, M., Assembly of the major and minor capsid proteins of HPV 33 into virus-like particles and tubular structures in insect cells. Virology, 200, 504-512 (1994).
28. WALBOOMERS, J.M.M., DE RODA HUSMAN, A-M., SNIJDERS, P.J.F., STEL, H.V., RISSE, E.K.J., HELMERHORST, T.J.M., VOORHORST, F.J. and MEIJER, C.J.L.M., Human papillomavirus in false-negative archival cervical smears: implications for screening for cervical cancer. J. Clin. Pathol., 48, 728-732 (1995).
29. WIKSTRÖM, A., VAN DOORNUM, G.J.J., QUINT, W.G.V., SCHILLER, J.T. and DILLNER, J., Identification of human-papillomavirus seroconversions. J. gen. Virol., 76, 529-539 (1995).
30. ZUR HAUSEN, H., Viruses in human cancers. Science, 254, 1167-1173 (1991).